Ivermectin (ivermectin)
Acne Antibiotics Topical Cream (Gram)
Last reviewed · Source: First Databank (FDB) drug data
Overview
Ivermectin, a semisynthetic, avermectin-derivative, is used topically as a pediculicide.
Ivermectin is a semisynthetic, avermectin-derivative used as an anthelmintic, pediculicide, and scabicide. Avermectins are macrocyclic lactones isolated from the fermentation products of Streptomyces avermitilis and are similar to macrolide antibacterials but possess no antibacterial properties. Ivermectin is a mixture of 2 chemically modified avermectins: at least 90% is 22,23-dihydroavermectin B1a (H2B1a) and less than 10% is 22,23-dihydroavermectin B1b (H2B1b).
Ivermectin binds selectively and with high affinity to glutamate-gated chloride ion channels in invertebrate nerve and muscle cells, leading to an increase in the permeability of the cell membrane to chloride ions with hyperpolarization of the cell leading to paralysis and death of the parasite. Ivermectin also appears to interact with other ligand-gated chloride channels, such as those gated by gamma-aminobutyric acid (GABA).
Topically applied ivermectin is pediculicidal, but is not ovicidal. In vitro studies indicate that ivermectin has activity against human head lice (Pediculus humanus capitis) and has shown activity against a permethrin-resistant strain. Topical administration has resulted in death of nearly all newly hatched nymphs and adult lice within 48 hours.
There is some evidence suggesting that ivermectin may interfere with louse mouthparts, resulting in impaired feeding in treated lice.
For the topical treatment of pediculosis capitis (head lice infestation), ivermectin is commercially available as a 0.5% lotion in a vehicle that includes olive oil, oleyl alcohol, Crodalan AWS, lanolin alcohol, cyclomethicone, shea butter, sodium citrate, sorbitan tristearate, methylparaben, propylparaben, and citric acid. The lotion is off-white to tan in color.
Low concentrations of ivermectin are absorbed following topical application. Following a single topical application of ivermectin 0.5% lotion in 20 children (6 months to 3 years of age) with head lice infestation, the mean peak plasma concentration of the drug was 0.24 ng/mL (lower limit of quantitation 0.05 ng/mL) and the mean area under the concentration-time curve (AUC) was 6.7 hrxng/mL. These values are lower than those observed following an oral dose of 165 mcg/kg of ivermectin.
Systemically absorbed ivermectin is metabolized in the liver, principally by CYP3A4, and eliminated almost exclusively in feces.
USES: This medication is used to treat a certain skin condition called rosacea, a type of adult acne. Ivermectin may help to decrease symptoms caused by rosacea, such as redness, swelling, and pimples.
Generic name: ivermectin
Pronunciation: (EYE-ver-MEK-tin)
Drug class: Acne Antibiotics
Therapeutic class: Dermatological
Reference product & biosimilars
No reference, biosimilar or interchangeable associated with this drug.
Today’s intelligence on Ivermectin
Indications
The following indications are listed for Ivermectin:
- Acne Rosacea
Also known as: Acne Erythematosa, Rosacea.
Dosing
No dosing information is available for this tab.
No dosing information is available for this tab.
| Drug label | Dosing type | Instructions |
|---|---|---|
| Ivermectin 1% Cream | Maintenance | Apply a pea-sized amount by topical route once daily to cover areas of face with thin layer avoiding the eyes and lips. |
| Drug label | Dosing type | Instructions |
|---|---|---|
| Ivermectin 1% Cream | Maintenance | Apply a pea-sized amount by topical route once daily to cover areas of face with thin layer avoiding the eyes and lips. |
Drug interactions
Drug interaction studies have not been performed to date with ivermectin 0.5% lotion.
There are no contraindication interactions for this drug.
There are no severe interactions for this drug.
There are no moderate interactions for this drug.
Contraindications
The manufacturer states there are no contraindications to use of ivermectin 0.5% lotion.
There are no contraindication contraindications for this drug.
There are no severe contraindications for this drug.
There are no moderate contraindications for this drug.
Adverse reactions
Conjunctivitis, ocular hyperemia, eye irritation, dandruff, dry skin, and burning skin sensation were reported in less than 1% of patients 6 months of age or older after a single 10-minute topical application of ivermectin 0.5% lotion.
Rare or Very Rare
- Allergic dermatitis
- Dyspnea
- Ocular irritation
- Skin rash
Rare or Very Rare
- Conjunctival hyperemia
- Contact dermatitis
- Dandruff
- Dry skin
- Ocular redness
- Skin irritation
- Stinging of skin
- Treatment site sequelae
Precautions
No enhanced messaging available.
Safety and efficacy of ivermectin 0.5% lotion have not been established in children younger than 6 months of age. Because these young children have a greater skin surface area to body mass ratio and potentially immature skin barrier, systemic absorption may be increased and children younger than 6 months of age may be at increased risk of ivermectin toxicity. Ivermectin 0.5% lotion should not be used in children younger than 6 months of age.
The lotion should be kept out of the reach of children and should be used only under the direct supervision of an adult.
Category C. (See Users Guide)
Orally administered ivermectin is distributed into milk in low concentrations. Since it is not known if ivermectin is distributed into milk following topical administration, the 0.5% lotion should be used with caution in nursing women.
Clinical studies of ivermectin 0.5% lotion did not include sufficient numbers of patients 65 years of age or older to determine whether geriatric patients respond differently than younger adults; other clinical experience has not identified differences in response between geriatric and younger patients.
ICD codes
| Code | Type | Description |
|---|---|---|
| Acne rosacea | ||
| L71.0 | ICD10CM | Perioral dermatitis |
| L71.9 | ICD10CM | Rosacea, unspecified |
ICD code information from First Databank (FDB).
Formulary status
Search health-plan coverage for this drug by ZIP code.
Choose the first character of a health plan name.
Last reviewed · Source: First Databank (FDB) drug data
On this page
Actions
Sign in to save favorites
Saving this drug requires a free Physicians Office Resource account.